PTPRC and hydrops fetalis: Flow cytometry of single cell suspensions of skin samples confirmed reduced expression of MHC class I and II on HF (CD45-EpCAM+CD200+) in Ifidancitinib-treated mice compared to controls (Figure 2D) (20).